These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2580107)

  • 1. Evaluation of antiarrhythmic drug efficacy using holter electrocardiographic technique.
    Tanabe T; Yoshikawa H; Tagawa R; Furuya H; Ide M; Goto Y
    Jpn Circ J; 1985 Mar; 49(3):337-44. PubMed ID: 2580107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mexiletine and disopyramide suppress ventricular premature contractions (VPC) irrespective of the relationship between the VPC and the underlying heart rate.
    Saikawa T; Nakagawa M; Takahashi N; Ishida S; Fujino T; Ito M; Shimoyama N; Hara M; Yonemochi H; Maeda T
    Jpn Heart J; 1992 Sep; 33(5):665-78. PubMed ID: 1283888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic efficacy of Ethmozine (moricizine HCl) compared with disopyramide and propranolol.
    Pratt CM; Butman SM; Young JB; Knoll M; English LD
    Am J Cardiol; 1987 Oct; 60(11):52F-58F. PubMed ID: 3310586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination antiarrhythmic treatment among class Ia, Ib, and II agents for ventricular arrhythmias.
    Tanabe T
    Cardiovasc Drugs Ther; 1991 Aug; 5 Suppl 4():827-34. PubMed ID: 1931759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug therapy of arrhythmia in coronary cardiopathy].
    Lüderitz B
    Clin Ter; 1983 Apr; 105(1):3-11. PubMed ID: 6189663
    [No Abstract]   [Full Text] [Related]  

  • 6. Suppression of ventricular premature contractions possibly related to triggered activity by oral diltiazem and atenolol.
    Ito M; Tsumabuki S; Maeda Y; Arita M; Saikawa T; Ito S; Fujino T; Fukumoto T; Yamada K; Kikuchi Y
    Jpn Circ J; 1987 Feb; 51(2):217-29. PubMed ID: 2439719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous variability and detection of repetitive extrasystoles during simulated acute antiarrhythmic testing.
    Hernández-Acosta K; Groning E; Rodríguez-Bereao C; Hernández-Cañero A; García-Barreto D
    Cor Vasa; 1985; 27(4):287-92. PubMed ID: 2414060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of ventricular premature contractions continues after the washout of antiarrhythmic drugs.
    Saikawa T; Ito M; Nakagawa M; Shimoyama N; Hara M; Yonemochi H; Maeda T; Inoue T; Takaki R; Arita M
    Jpn Circ J; 1993 Jan; 57(1):55-62. PubMed ID: 8437342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of disopyramide and mexiletine used alone and in combination for ventricular arrhythmias in patients with and without overt heart disease.
    Tanabe T; Takahashi K; Yoshioka K; Goto Y
    Int J Cardiol; 1991 Sep; 32(3):303-12. PubMed ID: 1724233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of antiarrhythmic drugs: a review and overview, part II.
    Singh BN; Cho YW; Kuemmerle HP
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):185-99. PubMed ID: 6788721
    [No Abstract]   [Full Text] [Related]  

  • 11. Spontaneous variability in the frequency of ventricular premature complexes over prolonged intervals and implications for antiarrhythmic treatment.
    Toivonen L
    Am J Cardiol; 1987 Sep; 60(7):608-12. PubMed ID: 2442995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical study on coupling interval of ventricular premature contraction in patients with organic heart disease.
    Fujimoto Y; Fukuki M; Hirokane Y; Kotake H; Mashiba H
    Jpn Circ J; 1991 Dec; 55(12):1174-80. PubMed ID: 1722517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of oral diltiazem on ventricular premature contractions.
    Ito M; Maeda Y; Arita M; Ito S; Saikawa T; Omura I; Fujino T; Fukumoto T; Kikuchi Y; Yamada K
    J Electrocardiol; 1986 Jan; 19(1):59-66. PubMed ID: 2433378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of ventricular arrhythmias in patients with dilated cardiomyopathy--relationship between the effects of antiarrhythmic agents and severity of myocardial lesions.
    Takarada A; Yokota Y; Fukuzaki H
    Jpn Circ J; 1990 Mar; 54(3):260-71. PubMed ID: 2366310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Day-to-day variation of the frequency of ventricular premature contractions depends on variation of heart rates.
    Tsumabuki S; Ito M; Arita M; Saikawa T; Ito S
    Jpn Circ J; 1988 Nov; 52(11):1231-9. PubMed ID: 2465423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The usefulness of Holter monitoring in the evaluation of antiarrhythmic drug efficacy for tachycardia.
    Yanaga T; Ichimaru Y; Ueno T; Hata Y; Okamoto K; Kodama Y; Otsuka K
    Jpn Circ J; 1983 Jan; 47(1):139-52. PubMed ID: 6827771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cumulative effects of heart beat on ventricular premature contractions suggesting possible involvement of triggered activity.
    Koumatsu K; Ito M; Fujino T; Saikawa T; Arita M
    Jpn Circ J; 1993 Jun; 57(6):503-11. PubMed ID: 8340997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, crossover comparison of flecainide acetate and disopyramide phosphate in the treatment of ventricular premature complexes.
    Kjekshus J; Bathen J; Orning OM; Storstein L
    Am J Cardiol; 1984 Feb; 53(5):72B-78B. PubMed ID: 6421140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New antiarrhythmic agents: amiodarone, aprindine, disopyramide, ethmozin, mexiletine, tocainide, verapamil.
    Zipes DP; Troup PJ
    Am J Cardiol; 1978 May; 41(6):1005-24. PubMed ID: 352121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effectiveness and plasma levels of single or combination use of class I antiarrhythmic agents for ventricular arrhythmias.
    Tanabe T; Yoshikawa H; Furuya H; Goto Y
    Jpn Circ J; 1988 Mar; 52(3):298-305. PubMed ID: 3373722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.